Dear EditorWe read carefully the review of Vigar V. et al. [1]. Chronic degenerative non-communicable diseases (CDNCD) are the most frequent causes of prolonged disability and death worldwide [2]. Epidemiological studies have shown the associations among diet, lifestyle, and the incidence and severity of CDNCDs. Personalized food patterns have started to be proposed, worldwide, for their prevention [3].Numerous studies indicate that a healthy and organic diet provides higher content of bioactive compounds and lower content of unhealthy substances, such as persistent pollutants, their metabolites, pesticides, fertilizers [4,5]. Therefore, the consumption of organic food contributes to maintaining an optimal health status and decreases the risk of CDNCD. For these reasons, it is fundamental to the passage from the Environmental to the Health Impact Assessment, in maintaining the nutritional quality of specific food or products along the entire supply chain, according to the Nutrient and Hazard Analysis of Critical Control Point (NACCP) process [6].A bias highlighted by Vigar V. et al. [1] on the clinical trial data reported was related to the fact that these trials “were not randomized, providing one diet followed by the alternate diet for all participants concurrently”. The authors cited two papers of the same group [7,8]. Actually, in these articles, it is pointed out that the sequential administration of the conventional diet before and the organic one after did not negatively influence the statistical results since a marked improvement in biochemical and body composition parameters was observed only at the end of the last dietetic treatment with organic foods.Therefore, Vigar V. et al. [1] highlighted the importance of organic food certification, necessary in order to know the true effects on human health. The authors, however, underlined that some papers did not report the certification of organic food used [7,8,9].About this, it is necessary to dwell on the definition itself, foreseen by the legislation of many countries [10]. In Europe, for example, organic production is regulated by EU Regulation 834/2007. Consumers are guaranteed that when they buy an organic product with an EU label, it is organic. So, Vigar V. et al. [1], in questioning the trustworthiness of results on organic food consumption, make the mistake of underestimating that, at least in Europe, the definition of organic food is dictated by a specific law. For this reason, it is not necessary to define the certification of organic products, as only products that are in accord with the European regulation can be defined as organic and receive the guarantee mark. In any case, De Lorenzo et al. [8], in the introduction of the paper, clearly referred to the European Community Regulations.Based on these observations, the authors should have been less harsh in evaluating the bias and better considered the works cited, without contesting the observational data.
Authors: Abdallah S Daar; Peter A Singer; Deepa Leah Persad; Stig K Pramming; David R Matthews; Robert Beaglehole; Alan Bernstein; Leszek K Borysiewicz; Stephen Colagiuri; Nirmal Ganguly; Roger I Glass; Diane T Finegood; Jeffrey Koplan; Elizabeth G Nabel; George Sarna; Nizal Sarrafzadegan; Richard Smith; Derek Yach; John Bell Journal: Nature Date: 2007-11-22 Impact factor: 49.962
Authors: A De Lorenzo; A Noce; M Bigioni; V Calabrese; D G Della Rocca; N Di Daniele; C Tozzo; Laura Di Renzo Journal: Curr Pharm Des Date: 2010 Impact factor: 3.116
Authors: Sara Hurtado-Barroso; Anna Tresserra-Rimbau; Anna Vallverdú-Queralt; Rosa María Lamuela-Raventós Journal: Crit Rev Food Sci Nutr Date: 2017-11-30 Impact factor: 11.176
Authors: L Di Renzo; D Di Pierro; M Bigioni; V Sodi; F Galvano; R Cianci; L La Fauci; A De Lorenzo Journal: Eur Rev Med Pharmacol Sci Date: 2007 May-Jun Impact factor: 3.507
Authors: Laura Di Renzo; Carmen Colica; Alberto Carraro; Beniamino Cenci Goga; Luigi Tonino Marsella; Roberto Botta; Maria Laura Colombo; Santo Gratteri; Ting Fa Margherita Chang; Maurizio Droli; Francesca Sarlo; Antonino De Lorenzo Journal: J Transl Med Date: 2015-04-23 Impact factor: 5.531
Authors: Silvan Licher; Alis Heshmatollah; Kimberly D van der Willik; Bruno H Ch Stricker; Rikje Ruiter; Emmely W de Roos; Lies Lahousse; Peter J Koudstaal; Albert Hofman; Lana Fani; Guy G O Brusselle; Daniel Bos; Banafsheh Arshi; Maryam Kavousi; Maarten J G Leening; M Kamran Ikram; M Arfan Ikram Journal: PLoS Med Date: 2019-02-04 Impact factor: 11.069